Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 24 | 2024 | 287 | 6.320 |
Why?
|
| Trypanosoma cruzi | 24 | 2024 | 229 | 6.130 |
Why?
|
| Chagas Cardiomyopathy | 6 | 2021 | 45 | 2.490 |
Why?
|
| Vaccines | 6 | 2023 | 369 | 2.070 |
Why?
|
| Trypanocidal Agents | 4 | 2023 | 27 | 1.860 |
Why?
|
| Nitroimidazoles | 4 | 2023 | 45 | 1.850 |
Why?
|
| Protozoan Vaccines | 10 | 2024 | 96 | 1.580 |
Why?
|
| Parasites | 2 | 2023 | 31 | 0.910 |
Why?
|
| Antibodies, Protozoan | 5 | 2022 | 72 | 0.910 |
Why?
|
| Ascaris suum | 3 | 2020 | 27 | 0.820 |
Why?
|
| Antigens, Protozoan | 4 | 2024 | 65 | 0.790 |
Why?
|
| Monkey Diseases | 1 | 2020 | 18 | 0.690 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 19 | 0.670 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 44 | 0.670 |
Why?
|
| Lymphokines | 1 | 2019 | 66 | 0.670 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 219 | 0.650 |
Why?
|
| Microbiota | 2 | 2023 | 392 | 0.650 |
Why?
|
| Protective Agents | 1 | 2018 | 31 | 0.610 |
Why?
|
| Immunity, Cellular | 2 | 2022 | 202 | 0.600 |
Why?
|
| HLA-A Antigens | 1 | 2018 | 35 | 0.590 |
Why?
|
| HLA-B Antigens | 1 | 2018 | 27 | 0.590 |
Why?
|
| Myocardium | 2 | 2019 | 1001 | 0.570 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 771 | 0.570 |
Why?
|
| Ascariasis | 4 | 2020 | 66 | 0.550 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 459 | 0.550 |
Why?
|
| Animals | 32 | 2024 | 34134 | 0.550 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 609 | 0.540 |
Why?
|
| Immunologic Memory | 1 | 2018 | 185 | 0.530 |
Why?
|
| Mice | 20 | 2024 | 17739 | 0.520 |
Why?
|
| Mice, Inbred BALB C | 12 | 2022 | 1000 | 0.500 |
Why?
|
| Vaccination | 8 | 2022 | 953 | 0.490 |
Why?
|
| Protozoan Proteins | 3 | 2022 | 108 | 0.460 |
Why?
|
| Leishmania | 2 | 2023 | 28 | 0.420 |
Why?
|
| Leishmaniasis | 2 | 2023 | 33 | 0.420 |
Why?
|
| Heart | 5 | 2023 | 724 | 0.370 |
Why?
|
| Antigens, Helminth | 5 | 2020 | 190 | 0.360 |
Why?
|
| Recombinant Proteins | 5 | 2023 | 1392 | 0.360 |
Why?
|
| Trichuriasis | 3 | 2022 | 31 | 0.350 |
Why?
|
| Immunization | 5 | 2022 | 307 | 0.340 |
Why?
|
| Antibodies, Helminth | 3 | 2020 | 124 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 391 | 0.320 |
Why?
|
| Fibrosis | 2 | 2019 | 436 | 0.280 |
Why?
|
| Superantigens | 2 | 2017 | 20 | 0.270 |
Why?
|
| Cytokines | 4 | 2022 | 1272 | 0.260 |
Why?
|
| Female | 17 | 2023 | 66254 | 0.260 |
Why?
|
| Adjuvants, Immunologic | 5 | 2022 | 378 | 0.260 |
Why?
|
| Hepatomegaly | 1 | 2023 | 21 | 0.220 |
Why?
|
| PPAR alpha | 1 | 2023 | 53 | 0.220 |
Why?
|
| Leishmania mexicana | 1 | 2023 | 5 | 0.210 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 4344 | 0.210 |
Why?
|
| Interferon-gamma | 4 | 2019 | 503 | 0.210 |
Why?
|
| Interleukin-10 | 2 | 2018 | 173 | 0.210 |
Why?
|
| Th2 Cells | 2 | 2017 | 187 | 0.200 |
Why?
|
| Immunoglobulin M | 3 | 2018 | 211 | 0.200 |
Why?
|
| Th1 Cells | 2 | 2022 | 153 | 0.200 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.190 |
Why?
|
| Metabolome | 2 | 2021 | 294 | 0.190 |
Why?
|
| Parasite Load | 2 | 2018 | 31 | 0.180 |
Why?
|
| Antigenic Variation | 1 | 2021 | 39 | 0.180 |
Why?
|
| Tropism | 1 | 2020 | 9 | 0.180 |
Why?
|
| Larva | 2 | 2018 | 248 | 0.180 |
Why?
|
| Mexico | 2 | 2018 | 180 | 0.180 |
Why?
|
| Interleukin-17 | 1 | 2021 | 119 | 0.170 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 121 | 0.170 |
Why?
|
| Flow Cytometry | 2 | 2023 | 804 | 0.170 |
Why?
|
| Phospholipids | 1 | 2020 | 107 | 0.170 |
Why?
|
| Endothelin-1 | 1 | 2019 | 39 | 0.170 |
Why?
|
| Cysteine | 2 | 2017 | 135 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 327 | 0.160 |
Why?
|
| Parasitemia | 1 | 2019 | 24 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 143 | 0.160 |
Why?
|
| Helminth Proteins | 1 | 2020 | 101 | 0.160 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 154 | 0.160 |
Why?
|
| Antibodies, Catalytic | 1 | 2018 | 7 | 0.160 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 151 | 0.160 |
Why?
|
| Swine Diseases | 1 | 2018 | 36 | 0.160 |
Why?
|
| Macaca mulatta | 1 | 2020 | 492 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 816 | 0.150 |
Why?
|
| Humans | 17 | 2024 | 124231 | 0.140 |
Why?
|
| Disease Progression | 2 | 2023 | 2037 | 0.140 |
Why?
|
| Immunity | 1 | 2018 | 190 | 0.140 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 125 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 1583 | 0.140 |
Why?
|
| Immunophenotyping | 1 | 2018 | 329 | 0.140 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 195 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 997 | 0.130 |
Why?
|
| Host-Parasite Interactions | 1 | 2016 | 70 | 0.130 |
Why?
|
| Vaccines, Synthetic | 4 | 2022 | 317 | 0.130 |
Why?
|
| Trichuris | 3 | 2022 | 26 | 0.130 |
Why?
|
| Gene Frequency | 1 | 2018 | 718 | 0.130 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 159 | 0.130 |
Why?
|
| Insect Vectors | 1 | 2016 | 109 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1690 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2019 | 891 | 0.120 |
Why?
|
| Swine | 1 | 2018 | 1170 | 0.120 |
Why?
|
| Acute Disease | 1 | 2018 | 1098 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 626 | 0.120 |
Why?
|
| Echocardiography | 1 | 2019 | 1055 | 0.110 |
Why?
|
| Vaccines, Combined | 2 | 2023 | 39 | 0.110 |
Why?
|
| Basophils | 1 | 2012 | 11 | 0.100 |
Why?
|
| Histamine Release | 1 | 2012 | 10 | 0.100 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2012 | 26 | 0.100 |
Why?
|
| Hookworm Infections | 1 | 2014 | 124 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2017 | 663 | 0.100 |
Why?
|
| B-Lymphocytes | 3 | 2021 | 519 | 0.100 |
Why?
|
| HIV Infections | 1 | 2024 | 1869 | 0.100 |
Why?
|
| Global Health | 1 | 2016 | 555 | 0.100 |
Why?
|
| Necator americanus | 1 | 2012 | 91 | 0.100 |
Why?
|
| Genotype | 1 | 2018 | 2548 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 1764 | 0.100 |
Why?
|
| Immunoglobulin E | 1 | 2012 | 162 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1491 | 0.090 |
Why?
|
| Lung | 1 | 2018 | 1485 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2018 | 2308 | 0.090 |
Why?
|
| Biomarkers | 1 | 2019 | 2972 | 0.090 |
Why?
|
| Interleukin-4 | 2 | 2022 | 138 | 0.090 |
Why?
|
| Antibody Formation | 2 | 2022 | 259 | 0.080 |
Why?
|
| Male | 3 | 2020 | 60871 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3572 | 0.070 |
Why?
|
| Leishmania major | 1 | 2007 | 24 | 0.070 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2007 | 48 | 0.070 |
Why?
|
| Pregnancy | 1 | 2020 | 7238 | 0.070 |
Why?
|
| Soil | 2 | 2020 | 55 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2023 | 768 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 217 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 469 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 365 | 0.060 |
Why?
|
| Technology | 1 | 2024 | 64 | 0.050 |
Why?
|
| Dogs | 2 | 2016 | 765 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 384 | 0.050 |
Why?
|
| Campylobacter jejuni | 1 | 2003 | 4 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1478 | 0.050 |
Why?
|
| Campylobacter Infections | 1 | 2003 | 34 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 180 | 0.050 |
Why?
|
| Sus scrofa | 1 | 2003 | 125 | 0.050 |
Why?
|
| Antiparasitic Agents | 1 | 2022 | 31 | 0.050 |
Why?
|
| Mice, Inbred AKR | 1 | 2022 | 14 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 16208 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2022 | 87 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 132 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2022 | 84 | 0.050 |
Why?
|
| Hybridomas | 1 | 2021 | 41 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 205 | 0.050 |
Why?
|
| Synteny | 1 | 2021 | 74 | 0.050 |
Why?
|
| Epitopes | 1 | 2022 | 433 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 568 | 0.040 |
Why?
|
| Colon | 1 | 2003 | 353 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 1015 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 298 | 0.040 |
Why?
|
| Aged | 1 | 2018 | 19383 | 0.040 |
Why?
|
| Middle Aged | 1 | 2018 | 26363 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 696 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2017 | 54 | 0.040 |
Why?
|
| Cholera Toxin | 1 | 2017 | 45 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2024 | 2821 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2017 | 44 | 0.040 |
Why?
|
| Adult | 1 | 2018 | 29350 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2017 | 163 | 0.030 |
Why?
|
| Coyotes | 1 | 2016 | 3 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2017 | 100 | 0.030 |
Why?
|
| Animals, Domestic | 1 | 2016 | 31 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 174 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 59 | 0.030 |
Why?
|
| Triatoma | 1 | 2016 | 29 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 289 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 410 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 325 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 625 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2697 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 202 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 347 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1935 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2016 | 246 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 403 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 604 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 374 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 425 | 0.030 |
Why?
|
| Ascaris lumbricoides | 1 | 2014 | 19 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4427 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2014 | 55 | 0.030 |
Why?
|
| Ancylostomatoidea | 1 | 2014 | 59 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2017 | 941 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2012 | 41 | 0.030 |
Why?
|
| Pichia | 1 | 2012 | 56 | 0.030 |
Why?
|
| Vaccines, Subunit | 1 | 2012 | 67 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 411 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2012 | 170 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2012 | 182 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2427 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 511 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3257 | 0.020 |
Why?
|
| United States | 1 | 2024 | 10754 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3586 | 0.020 |
Why?
|
| Ear | 1 | 2007 | 25 | 0.020 |
Why?
|
| Dermis | 1 | 2007 | 24 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1569 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2007 | 124 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2007 | 96 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2535 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2007 | 376 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 5803 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 395 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12260 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 1414 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 3755 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3125 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 4529 | 0.010 |
Why?
|